Life Sciences & Healthcare

Our Life Sciences & Healthcare Industry group brings together the firm’s market‑leading capabilities to support clients facing high‑stakes regulatory, transactional, and litigation challenges across the full continuum of care and the entire product lifecycle. We deliver practical, commercially grounded guidance at the intersection of FDA law, health law, product liability, internal and government investigations, M&A, appellate litigation, data privacy and security, government advocacy and more. 

Our lawyers help a broad range of industry clients navigate complex legal and operational issues that shape how life science and healthcare companies operate in a dynamic regulatory environment and how innovative products and services are developed, approved, and commercialized.

At the forefront of industry innovation, our regulatory and corporate teams assist development‑stage and emerging‑technology clients with business-critical corporate and product development advice to help facilitate successful commercialization strategies. We also help these clients evolve with market trends by leveraging our extensive, industry-specific experience with product licensing deals, innovative care delivery models, IP protection agreements, and market access counseling experience.  

With deep experience before key agencies – including the FDA, CMS, and HHS – our team helps clients anticipate policy and reimbursement shifts, manage enforcement risk, and advance strategic objectives in an increasingly complex and highly regulated environment. We counsel on development and approval strategy, regulatory compliance and quality systems, clinical trials, advertising and promotion, reimbursement strategy, managed care, antitrust, fraud and abuse, intellectual property, data privacy and security, and complex transactions, including mergers and acquisitions.

When matters escalate, we represent clients in investigations, inspections, recalls, and litigation, including product liability and appellate disputes. We coordinate seamlessly with colleagues across practices, disciplines, and geographies, enabling us to support transformative partnerships and provide industry clients with truly integrated, 360‑degree coverage.

Our team is recognized as an established leader in the life sciences and healthcare industry, with a long history as counsel of choice for pharmaceutical, biologics, and medical device manufacturers, as well as major hospitals and health systems. Chambers and Legal 500 consistently rank our practice and its lawyers among the leading firms in this space.

a machine with pills on it

Related Lawyers

Mark D. Polston
Partner
Government Matters & Regulation
John D. Shakow
Partner
Government Matters & Regulation
Amanda J. Klingler
Partner
Government Matters & Regulation
Stephanie F. Johnson
Partner
Government Matters & Regulation
Andrew T. Bayman (Andy)
Partner
Product Liability & Mass Torts
J. Michael Taylor
Partner
Government Matters & Regulation
Mark A. Jensen
Partner
Special Matters & Government Investigations
Adam C. Solander
Partner
Government Matters & Regulation
Dr. Peter Memminger
Partner
Corporate

Featured Insights

Featured Events

a blue and green background
Conference
September 15, 2026
Medical Device Summit 2026
a blue and green background
Webinar
June 23, 2026
Transparency in the Pharmaceutical Sector

Latest News